https://www.nxtpsychedelics.com/news/articles/psychedelics/mindbio-therapeutics-corp-begins-selection-of-participants-for-its-phase-2-randomized-double-blind-and-placebo-controlled-clinical-trial-in-advanced-stage-cancer-patients-using-microdoses-of-lylergic/